# How does Semax affect oxidative stress and recovery after spinal cord injury?

Canonical source: https://retacompare.com/research/how-does-semax-affect-oxidative-stress-and-recovery-after-spinal-cord-injury

Peptide Longevity Q&A · 2025-11-01


    Research indicates that Semax promotes functional recovery after spinal cord injury by reducing oxidative stress and inhibiting lysosomal membrane permeabilization. This neuroprotective effect is linked to its modulation of the μ-opioid receptor and regulation of deubiquitination processes.

 What the research shows

The study investigated the effects of Semax, a synthetic heptapeptide, on functional recovery following spinal cord injury (SCI) in a preclinical mouse model. Female C57BL/6 mice underwent spinal cord impact at the T9-T10 level, and various assessments were conducted to evaluate recovery. These included histochemical methods, footprint analysis, Basso scores, and inclined plane tests. The research focused on Semax's ability to modulate lysosomal membrane permeabilization (LMP) and ubiquitination, which are critical factors in the pathophysiology of SCI. The study utilized immunofluorescence, Western blotting, RT-qPCR, and transmission electron microscopy to analyze marker levels and distributions. Additionally, RNA sequencing, network pharmacology, and molecular docking were employed to identify potential molecular targets of Semax.

 Why it matters for longevity

Oxidative stress is a significant contributor to cellular aging and neurodegenerative conditions. By reducing oxidative stress and promoting neuronal recovery, Semax may enhance longevity and healthspan, particularly in the context of age-related neurodegeneration. The findings suggest that Semax's neuroprotective properties could be beneficial not only for spinal cord injuries but also for broader applications in aging-related cognitive decline and neuroinflammation. Understanding how Semax interacts with the μ-opioid receptor and regulates deubiquitination processes may pave the way for developing therapeutic strategies aimed at improving resilience against age-related neurological issues.

 Key findings at a glance

Semax improved functional recovery in a mouse model of spinal cord injury.

It reduced oxidative stress and inhibited lysosomal membrane permeabilization.

The peptide targeted the μ-opioid receptor, influencing recovery pathways.

Semax regulated the ubiquitin specific protease USP18, affecting deubiquitination.

Inhibition of LMP-related pyroptosis was observed with Semax treatment.

 How Semax works (background)

Semax is a synthetic peptide derived from the adrenocorticotropic hormone (ACTH) fragment. It exhibits neuroprotective properties by modulating various biological pathways involved in neuronal health. The peptide has been shown to influence oxidative stress levels, which are critical in the context of neuronal damage and recovery. Research indicates that Semax interacts with the μ-opioid receptor, which plays a role in pain modulation and neuroprotection. By targeting this receptor, Semax may enhance the stability and functionality of lysosomal membranes, thereby reducing cell death and promoting recovery processes following spinal cord injury. Additionally, its regulation of deubiquitination processes may contribute to improved neuronal survival and function.

 Safety, caveats, and what we don't yet know

While the research demonstrates Semax's potential benefits in a preclinical model, further studies are necessary to confirm these effects in human populations. The current findings are based on animal models, and the translation of these results to clinical settings requires careful consideration. Potential side effects, long-term safety, and optimal dosing regimens have not been extensively studied. Additionally, the mechanisms underlying Semax's effects on various biological pathways need further elucidation to ensure comprehensive understanding and application.

 Bottom line

Semax appears to support functional recovery after spinal cord injury by reducing oxidative stress and modulating key biological pathways. These findings highlight its potential relevance in addressing age-related neurodegenerative conditions.

 Related questions

 Can Semax enhance cognitive function in aging populations?

Research suggests that Semax may improve cognitive function due to its neuroprotective properties, particularly in models of neuroinflammation and injury. Its ability to modulate oxidative stress could also play a role in cognitive health during aging.

 Does Semax have potential for treating neurodegenerative diseases?

Given its neuroprotective effects and ability to reduce oxidative stress, Semax may hold promise for treating neurodegenerative diseases. However, more research is needed to confirm its efficacy and safety in human subjects.

 What other peptides are being studied for neuroprotection?

Several peptides are currently under investigation for their neuroprotective effects, including BPC-157 and N-acetylcysteine. These peptides are being studied for their roles in reducing oxidative stress and promoting neuronal health.

 Source: PubMed · Br J Pharmacol · published 2025-11-01.

## Sources

- PubMed · Br J Pharmacol: https://pubmed.ncbi.nlm.nih.gov/40692165/